Name : Mr. MOKTAR KHAN Patient UID.

: 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
COMPLETE BLOOD COUNT (CBC),WHOLE BLOOD EDTA
HAEMOGLOBIN (Hb) 13.2 g/dL 13.0-17.0
Methodology: colorimetric method
RED BLOOD CELLS- RBC COUNT 5.29 millions/mm³ 4.5 - 5.5
Methodology: electric impedance
PACKED CELL VOLUME (PCV) -HEMATOCRIT 41.4 % 40.0-50.0
Methodology: Pulse Height detection method
MCV 78.26 fL 83-101
Methodology: Automated/Calculated
MCH 24.95 pg 27.0-32.0
Methodology: by Automated/Calculated
MCHC 31.88 g/dL 31.5-34.5
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.4 % 11.6-14.0
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-SD) 43.6 fL 39.0- 46.0
Methodology: Automated/Calculated
MENTZER INDEX 14.79
Methodology: Calculated
PLATELET COUNT 193 10^3/µL 150-410
Methodology: Electric impedance/Microscopy
PLATELET DISTRIBUTION WIDTH (PDW) 16 fL 9.00-17.00
Methodology: Calculated
PCT(PLATELETCRIT) 0.28 % 0.108-0.282
Methodology: Calculated
MEAN PLATELET VOLUME - MPV 14.7 fL 7.00-12.0
Methodology: Calculated
P-LCR 58.50 % 11.0-45.0
Methodology: Calculated
P-LCC 113.00 % 30.0-90.0
Methodology: Calculated
TOTAL LEUKOCYTE COUNT (TLC) 6.29 10^3/µL 4.00-10.0
Methodology: electric impedance
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 62 % 40 - 80
Methodology: Flow cytometry/Manual
Lymphocytes 33 % 20 - 40
Methodology: Flow cytometry/Manual

Page 1 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902
Eosinophils 02 % 1.00-6.00
Methodology: Flow cytometry/Manual
Monocytes 03 % 2.00-10.0
Methodology: Flow cytometry/Manual
Basophils 00 % 0.00-1.00
Methodology: Flow cytometry/Manual
ABSOLUTE NEUTROPHIL COUNT 3.9 10^3/µL 2.00-7.00
Methodology: Calculated
ABSOLUTE LYMPHOCYTE COUNT 2.08 10^3/µL 1.00-3.00
ABSOLUTE EOSINOPHIL COUNT 0.13 10^3/µL 0.02-0.50
Methodology: Calculated
ABSOLUTE MONOCYTE COUNT 0.19 10^3/µL 0.20-1.00
Methodology: Calculated
ABSOLUTE BASOPHIL COUNT 0.00 10^3/µL 0.02-0.10
Methodology: Calculated
CLINICAL NOTES
A complete blood count (CBC) is used to evaluate overall health and detect wide range of disorders, including anemia, infection and leukemia.
There have been some reports of WBC and platelet counts being lower in venous blood than in capillary blood samples ,although still within these reference ranges.

POSSIBLE CAUSES OF ABNORMAL PARAMETERS:-

High RBC, Hb, or HCT - dehydration, polycythemia, shock, chronic hypoxia
Low RBC, Hb, or HCT - anemia, thalassemia, and other hemoglobinopathies
Low MCV - microcytic anemia
High MCV - macrocytic anemia, liver disease
Low WBC - sepsis, marrow hypoplasia
High WBC - acute stress, infection, malignancies
Low platelets - risk of bleeding
High platelets - risk of thrombosis

Notes
1.Macrocytic Anemia/Dimorphic Anemia can have low platelet count.
2.Microcytic Anemia/Leucocytosis can have Reactive thrombocytosis.

For microcytic indices a Mentzer index of less than 13 suggests that the patient may have thalassemia trait, and an index of more than 13 suggests that the patient may
have iron deficiency.

Reference ranges are from Dacie and Lewis Practical Hematology 11th edition(2011)

*** End Of Report ***

Page 2 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
ERYTHROCYTE SEDIMENTATION RATE (ESR),WHOLE BLOOD EDTA
ESR [WESTERGREN] 25 mm/1st 0 - 15
Methodology: Sedimentation
CLINICAL NOTES
The erythrocyte sedimentation rate (ESR ) is a relatively simple, inexpensive, non-specific test that has been used for many years to help detect inflammation associated
with conditions such as infections, cancers, and autoimmune diseases.ESR is said to be a non-specific test because an elevated result often indicates the presence of
inflammation but does not tell the health practitioner exactly where the inflammation is in the body or what is causing it. An ESR can be affected by other conditions besides
inflammation. For this reason, the ESR is typically used in conjunction with other tests, such as C-reactive protein.ESR is used to help diagnose certain specific inflammatory
diseases, including temporal arteritis, systemic vasculitis and polymyalgia rheumatica. A significantly elevated ESR is one of the main test results used to support the
diagnosis.This test may also be used to monitor disease activity and response to therapy in both of the above diseases as well as some others, such as lupus.

Factors increasing ESR

-Old age
-Pregnancy
-Anemia
-Elevated fibrinogen
-Macrocytosis
Factors decreasing ESR
-Microcytosis
-Low fibrinogen
-Polycythemia
-Marked leukocytosis

Page 3 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 04:19PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:21PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
BLOOD GLUCOSE RANDOM
BLOOD GLUCOSE RANDOM,Plasma Sod.F 86.20 mg/dL 80.0-140.0
Methodology: Hexokinase
Interpretation

Elevated glucose levels (hyperglycemia) are most often encountered clinically in the setting of diabetes mellitus, but they may also occur with pancreatic neoplasms,
hyperthyroidism, and adrenocortical dysfunction. Decreased glucose levels (hypoglycemia) may result from endogenous or exogenous insulin excess, prolonged starvation,
or liver disease.

Fasting Glucose 2 HOURS PP Glucose Diagnosis

<100 <140 Normal
100 to 125 140 to 199 Pre Diabetes
>126 >200 Diabetes

Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not have it yet. A level of 126 mg/dL or above,
confirmed by repeating the test on another day, means a person has diabetes. IGT (2 hrs Post meal), means a person has an increased risk of developing type 2 diabetes
but does not have it yet. A 2-hour glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes
Ref : American Diabetes association standards of medical care.

*** End Of Report ***

Page 4 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:43PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

IMMUNOLOGY
Test Name Results Unit Bio. Ref. Interval
PSA (PROSTATE SPECIFIC ANTIGEN) -TOTAL
PSA TOTAL ,SERUM 0.273 ng/mL 0.00-4.00
Methodology: CLIA
CLINICAL NOTES:-Prostate-specific antigen (PSA)is a 34-kD glycoprotein produced almost exclusively by the prostate gland.PSA is normally present in the blood at very
low levels. Increased levels of PSA may suggest the presence of prostate cancer.

1.Immediate PSA testing following digital rectal examination, ejaculation, prostatic massage, indwelling catheterization, ultrasonography and needle biopsy of prostate is not
recommended as they falsely elevate levels
2. PSA values regardless of levels should not be interpreted as absolute evidence of the presence or absence of disease. All values should be correlated with clinical
findings and other investigations
3. Physiological decrease in PSA level by 18% has been observed in sedentary patients either due to supine position or suspended sexual activity

Clinical Use
• An aid in the early detection of Prostate cancer when used in conjunction with Digital rectal examination in males more than 50 years of age and in those with two or more
affected first degree relatives.
• Follow up and management of Prostate cancer patients
• Detect metastatic or persistent disease in patients following surgical or medical treatment of Prostate cancer

NOTE
PSA levels can be also increased by prostatitis, irritation, benign prostatic hyperplasia (BPH), and recent ejaculation, producing a false positive result. Digital rectal
examination (DRE) has been shown in several studies to produce an increase in PSA. However, the effect is clinically insignificant, since DRE causes the most substantial
increases in patients with PSA levels already elevated over 4.0 ng/mL.

Obesity has been reported to reduce serum PSA levels. Delayed early detection may partially explain worse outcomes in obese men with early prostate cancer. After
treatment, higher BMI also correlates to higher risk of recurrence.specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J
Urol. 1995 Sep;154(3):1090-1095. doi:10.1016/s0022-5347(01)66984-2

REFRENCE
1. Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020 Feb 25;58(3):326-339. doi: 10.1515/cclm-2019-0693
2. Catalona WJ: Prostate cancer screening. Med Clin North Am. 2018 Mar;102(2):199-214. doi:10.1016/j.mcna.2017.11.001
3. Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA.
1995:274(15);214-1220
4. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.
doi:10.1136/bmj.k3519

*** End Of Report ***

Page 5 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:45PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

IMMUNOLOGY
Test Name Results Unit Bio. Ref. Interval
THYROID PROFILE : T3, T4 & TSH(TFT)
TRIODOTHYRONINE TOTAL (T3),Serum 1.20 ng/mL 0.70-2.04
Methodology: ECLIA
THYROXINE TOTAL (T4),Serum 6.85 ug/dl 4.6-10.5
Methodology: ECLIA
THYROID STIMULATING HORMONE (TSH),Serum 1.43 µIU/ml 0.35-4.94
Methodology: CMIA
NOTE-TSH levels are subject to circardian variation,reaching peak levels between 2-4 AM and min between 6-10 PM. The variation is the order of 50% hence time of the day has influence on the
measures serum TSH concentration.Dose and time of drug intake also influence the test result.
Transient increase in TSH levels or abnormal TSH levels can be seen in some non thyroidal conditions,simoultaneous measurement of TSH with free T4 is useful in evaluating differantial diagnosis.

INTERPRETATION-Ultra Sensitive 4th generation assay

1.Primary hyperthyroidism is accompanied by ↑serum T3 & T4 values along with ↓ TSH level.
2.Low TSH,high FT4 and TSH receptor antibody(TRAb) +ve seen in patients with Graves disease
3.Low TSH,high FT4 and TSH receptor antibody(TRAb) -ve seen in patients with Toxic adenoma/Toxic Multinodular goiter
4.HighTSH,Low FT4 and Thyroid microsomal antibody increased seen in patients with Hashimotos thyroiditis
5.HighTSH,Low FT4 and Thyroid microsomal antibody normal seen in patients with Iodine deficiency/Congenital T4 synthesis deficiency
6.Low TSH,Low FT4 and TRH stimulation test -Delayed response seen in patients with Tertiary hypothyroidism
7.Primary hypothyroidism is accompanied by ↓ serum T3 and T4 values & ↑serum TSH levels
8.Normal T4 levels accompanied by ↑ T3 levels and low TSH are seen in patients with T3 Thyrotoxicosis
9.Normal or↓ T3 & ↑T4 levels indicate T4 Thyrotoxicosis ( problem is conversion of T4 to T3)
10.Normal T3 & T4 along with ↓ TSH indicate mild / Subclinical Hyperthyroidism .
11.Normal T3 & ↓ T4 along with ↑ TSH is seen in Hypothyroidism .
12.Normal T3 & T4 levels with ↑ TSH indicate Mild / Subclinical Hypothyroidism .
13.Slightly ↑ T3 levels may be found in pregnancy and in estrogen therapy while ↓ levels may be encountered in severe illness , malnutrition , renal failure and during therapy with drugs like
propanolol.
14.Although ↑ TSH levels are nearly always indicative of Primary Hypothroidism ,rarely they can result from TSH secreting pituitary tumours.

DURING PREGNANCY - REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association)
1st Trimester : 0.10-2.50 uIU/mL
2nd Trimester : 0.20-3.00 uIU/mL
3rd Trimester : 0.30-3.00 uIU/mL
The production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.

REMARK-Assay results should be interpreted in context to the clinical condition and associated results of other investigations. Previous treatment with corticosteroid therapy may result in lower TSH
levels while thyroid hormone levels are normal. Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. Abnormal thyroid test findings often found in
critically ill patients should be repeated after the critical nature of the condition is resolved.TSH is an important marker for the diagnosis of thyroid dysfunction.Recent studies have shown that the
TSH distribution progressively shifts to a higher concentration with age ,and it is debatable whether this is due to a real change with age or an increasing proportion of unrecognized thyroid disease in
the elderly.

*** End Of Report ***

Page 6 of 6
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
COMPLETE BLOOD COUNT (CBC),WHOLE BLOOD EDTA
HAEMOGLOBIN (Hb) 13.2 g/dL 13.0-17.0
Methodology: colorimetric method
RED BLOOD CELLS- RBC COUNT 5.29 millions/mm³ 4.5 - 5.5
Methodology: electric impedance
PACKED CELL VOLUME (PCV) -HEMATOCRIT 41.4 % 40.0-50.0
Methodology: Pulse Height detection method
MCV 78.26 fL 83-101
Methodology: Automated/Calculated
MCH 24.95 pg 27.0-32.0
Methodology: by Automated/Calculated
MCHC 31.88 g/dL 31.5-34.5
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.4 % 11.6-14.0
Methodology: Automated/Calculated
RED CELL DISTRIBUTION WIDTH (RDW-SD) 43.6 fL 39.0- 46.0
Methodology: Automated/Calculated
MENTZER INDEX 14.79
Methodology: Calculated
PLATELET COUNT 193 10^3/µL 150-410
Methodology: Electric impedance/Microscopy
PLATELET DISTRIBUTION WIDTH (PDW) 16 fL 9.00-17.00
Methodology: Calculated
PCT(PLATELETCRIT) 0.28 % 0.108-0.282
Methodology: Calculated
MEAN PLATELET VOLUME - MPV 14.7 fL 7.00-12.0
Methodology: Calculated
P-LCR 58.50 % 11.0-45.0
Methodology: Calculated
P-LCC 113.00 % 30.0-90.0
Methodology: Calculated
TOTAL LEUKOCYTE COUNT (TLC) 6.29 10^3/µL 4.00-10.0
Methodology: electric impedance
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 62 % 40 - 80
Methodology: Flow cytometry/Manual
Lymphocytes 33 % 20 - 40
Methodology: Flow cytometry/Manual

Page 1 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902
Eosinophils 02 % 1.00-6.00
Methodology: Flow cytometry/Manual
Monocytes 03 % 2.00-10.0
Methodology: Flow cytometry/Manual
Basophils 00 % 0.00-1.00
Methodology: Flow cytometry/Manual
ABSOLUTE NEUTROPHIL COUNT 3.9 10^3/µL 2.00-7.00
Methodology: Calculated
ABSOLUTE LYMPHOCYTE COUNT 2.08 10^3/µL 1.00-3.00
ABSOLUTE EOSINOPHIL COUNT 0.13 10^3/µL 0.02-0.50
Methodology: Calculated
ABSOLUTE MONOCYTE COUNT 0.19 10^3/µL 0.20-1.00
Methodology: Calculated
ABSOLUTE BASOPHIL COUNT 0.00 10^3/µL 0.02-0.10
Methodology: Calculated
CLINICAL NOTES
A complete blood count (CBC) is used to evaluate overall health and detect wide range of disorders, including anemia, infection and leukemia.
There have been some reports of WBC and platelet counts being lower in venous blood than in capillary blood samples ,although still within these reference ranges.

POSSIBLE CAUSES OF ABNORMAL PARAMETERS:-

High RBC, Hb, or HCT - dehydration, polycythemia, shock, chronic hypoxia
Low RBC, Hb, or HCT - anemia, thalassemia, and other hemoglobinopathies
Low MCV - microcytic anemia
High MCV - macrocytic anemia, liver disease
Low WBC - sepsis, marrow hypoplasia
High WBC - acute stress, infection, malignancies
Low platelets - risk of bleeding
High platelets - risk of thrombosis

Notes
1.Macrocytic Anemia/Dimorphic Anemia can have low platelet count.
2.Microcytic Anemia/Leucocytosis can have Reactive thrombocytosis.

For microcytic indices a Mentzer index of less than 13 suggests that the patient may have thalassemia trait, and an index of more than 13 suggests that the patient may
have iron deficiency.

Reference ranges are from Dacie and Lewis Practical Hematology 11th edition(2011)

*** End Of Report ***

Page 2 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:36PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
ERYTHROCYTE SEDIMENTATION RATE (ESR),WHOLE BLOOD EDTA
ESR [WESTERGREN] 25 mm/1st 0 - 15
Methodology: Sedimentation
CLINICAL NOTES
The erythrocyte sedimentation rate (ESR ) is a relatively simple, inexpensive, non-specific test that has been used for many years to help detect inflammation associated
with conditions such as infections, cancers, and autoimmune diseases.ESR is said to be a non-specific test because an elevated result often indicates the presence of
inflammation but does not tell the health practitioner exactly where the inflammation is in the body or what is causing it. An ESR can be affected by other conditions besides
inflammation. For this reason, the ESR is typically used in conjunction with other tests, such as C-reactive protein.ESR is used to help diagnose certain specific inflammatory
diseases, including temporal arteritis, systemic vasculitis and polymyalgia rheumatica. A significantly elevated ESR is one of the main test results used to support the
diagnosis.This test may also be used to monitor disease activity and response to therapy in both of the above diseases as well as some others, such as lupus.

Factors increasing ESR

-Old age
-Pregnancy
-Anemia
-Elevated fibrinogen
-Macrocytosis
Factors decreasing ESR
-Microcytosis
-Low fibrinogen
-Polycythemia
-Marked leukocytosis

*** End Of Report ***

Page 3 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 08:51PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
CREATININE-SERUM
CREATININE-SERUM 0.63 mg/dL 0.60-1.30
Methodology: Jaffe Kinetic
INTERPRETATION
Kidney function tests are group of tests that can be used to evaluate how well the kidneys are functioning.Creatinine is a waste product produced by muscles from the
breakdown of a compound called creatine . It is removed from the body by the kidneys, which filter almost all of it from the blood and release it into the urine. This test
measures the amount of creatinine in the blood and/or urine.Creatine is part of the cycle that produces energy needed to contract muscles. Both creatine and creatinine are
produced by the body at a relatively constant rate. Since almost all creatinine is filtered from the blood by the kidneys and released into the urine, blood levels are usually a
good indicator of how well the kidneys are working.

REMARK-The amount of creatinine you produce depends on your body size and your muscle mass. For this reason, creatinine levels are usually slightly higher in men than
in women and children.Certain drugs are nephrotoxic hence KFT is done before and after initiation of treatment with these drugs.

Higher than normal level may be due to: • Blockage in the urinary tract • Kidney problems, such as kidney damage or failure, infection, or reduced blood flow • Loss of
body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure
caused by pregnancy (preeclampsia)
Lower than normal level may be due to: • Myasthenia Gravis • Muscular dystrophy.Low serum creatinine values are rare; they almost always reflect low muscle mass.

*** End Of Report ***

Page 4 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 04:19PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:21PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
CREACTIVE PROTEIN - CRP (QUANTITATIVE)
CREACTIVE PROTEIN - CRP 2.10 mg/L 0-5
(QUANTITATIVE),Serum
Methodology: Turbidimetric
CLINICAL NOTES
CRP is an acute phase reactant, a protein made by the liver and released into the blood within a few hours after tissue injury, the start of an infection, or other cause of
inflammation. The CRP test is not diagnostic of any condition, but it can be used together with signs and symptoms and other tests to evaluate an individual for an acute or
chronic inflammatory condition.For example, CRP may be used to detect or monitor significant inflammation in an individual who is suspected of having an acute condition,
such as:A serious bacterial infection like sepsis, fungal infection,Pelvic inflammatory disease (PID).

Markedly increased levels can occur, for example, after trauma or a heart attack, with active or untreated autoimmune disorders, and with serious bacterial infections,
such as in sepsis. The level of CRP can jump as much as a thousand-fold in response to bacterial infection, and its rise in the blood can precede pain, fever, or other signs
and symptoms.

The CRP test is useful in monitoring people with chronic inflammatory conditions to detect flare-ups and/or to determine if treatment is effective. Some examples
include:Inflammatory bowel disease,Some forms of arthritis,Autoimmune diseases, such as lupus or vasculitis.

CRP may sometimes be ordered along with erythrocyte sedimentation rate (ESR), another test that detects inflammation. While the CRP test is not specific enough to
diagnose a particular disease, it does serve as a general marker for infection and inflammation, thus alerting health practitioners that further testing and treatment may be
necessary. Depending on the suspected cause, a number of other tests may be performed to identify the source of inflammation.

Interpretation of CRP levels:-

Refrence National library of Medicine-C Reactive Protein Sara M. Nehring; Amandeep Goyal; Bhupendra C. Patel(Last Update: July 18, 2022)
Less than 3 mg/L: Normal (level seen in most healthy adults).
3 to 10 mg/L: Normal or minor elevation (can be seen in obesity, pregnancy, depression, diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle, cigarette
smoking, and genetic polymorphisms).
10 to 100 mg/L: Moderate elevation (Systemic inflammation such as RA, SLE, or other autoimmune diseases, malignancies, myocardial infarction, pancreatitis, bronchitis).
More than 100 mg/L: Marked elevation (Acute bacterial infections, viral infections, systemic vasculitis, major trauma).
More than 500 mg/L: Severe elevation (Acute bacterial infections).
BLOOD GLUCOSE RANDOM
BLOOD GLUCOSE RANDOM,Plasma Sod.F 86.20 mg/dL 80.0-140.0
Methodology: Hexokinase
Interpretation

Elevated glucose levels (hyperglycemia) are most often encountered clinically in the setting of diabetes mellitus, but they may also occur with pancreatic neoplasms,
hyperthyroidism, and adrenocortical dysfunction. Decreased glucose levels (hypoglycemia) may result from endogenous or exogenous insulin excess, prolonged starvation,
or liver disease.

Fasting Glucose 2 HOURS PP Glucose Diagnosis

<100 <140 Normal
100 to 125 140 to 199 Pre Diabetes
>126 >200 Diabetes

Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not have it yet. A level of 126 mg/dL or above,
confirmed by repeating the test on another day, means a person has diabetes. IGT (2 hrs Post meal), means a person has an increased risk of developing type 2 diabetes
but does not have it yet. A 2-hour glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes
Ref : American Diabetes association standards of medical care.

Page 5 of 13
Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 04:19PM
Referred By : NA Received on : 01-Nov-2024 05:12PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:21PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

*** End Of Report ***

Page 6 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 08:51PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
UREA - SERUM
UREA - SERUM 20.3 mg/dL 19.0 - 44.0
Methodology: Urease UV
CLINICAL NOTES
Urea is a waste product formed in the liver when protein is metabolized into its component parts (amino acids). This process produces ammonia, which is then converted
into the less toxic waste product urea. This test measures the blood urea nitrogen (BUN) level in the blood. Sometimes, a BUN to creatinine ratio is calculated to help
determine the cause of elevated levels.Nitrogen is a component of both ammonia and urea. Urea and urea nitrogen are referred to somewhat interchangeably because urea
contains nitrogen and because urea/urea nitrogen is the "transport method" used by the body to rid itself of excess nitrogen. Urea is formed in and released by the liver into
the blood and is carried to the kidneys, where it is filtered out of the blood and released into the urine. Since this is an ongoing process, there is usually a small but stable
amount of urea nitrogen in the blood. However, when the kidneys cannot filter wastes out of the blood due to disease or damage, then the level of urea in the blood will rise.

Most diseases or conditions that affect the kidneys or liver have the potential to affect the amount of urea present in the blood. If increased amounts of urea are produced
by the liver or if the kidneys are not working properly and have difficulty filtering wastes out of the blood, then urea levels will rise in the blood. If significant liver damage or
disease inhibits the production of urea, then BUN levels may fall.

Conditions causing increased blood urea fall into three different categories: prerenal, renal, and postrenal.
1.Prerenal azotemia can be caused by
-decreased blood flow through the kidneys (e.g. low blood pressure, congestive heart failure, shock, bleeding, dehydration)
-increased production of urea in the liver via a high protein diet
-increased protein catabolism (e.g. stress, fever, major illness, corticosteroid therapy or gastrointestinal bleeding).

2.Renal causes can be attributed to decreased kidney function

-acute and chronic kidney failure,
-acute and chronic glomerular nephritis,
-tubular necrosis

3.Post renal causes can be due to decreased elimination of urea. These could be due to urinary outflow obstruction such as by calculi, tumours of the bladder or prostate,
or a severe infection.

*** End Of Report ***

Page 7 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 08:51PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
URIC ACID - SERUM
URIC ACID - SERUM 3.60 mg/dL 3.50 - 7.20
Methodology: URICASE-POD
COMMENT-
The final breakdown product of purine catabolism in humans is uric acid. The liver and intestinal mucosa produce most of the uric acid. The kidneys eliminate two thirds of
the uric acid, with the GI tract excreting the other one third.

Elevated uric acid levels can be seen in the following:

Gout,Renal failure,Destruction of massive amounts of nucleoproteins (leukemia, anemia, chemotherapy, toxemia of pregnancy, psoriasis, sickle cell anemia, hemolytic
anemia, polycythemia, resulting pneumonia),Drugs (especially diuretics, barbiturates),Lactic acidosis,Hypothyroidism,Chronic kidney disease,Parathyroid diseases,Low-
dose salicylates,Metabolic acidosis, Sarcoidosis
Diet (high-protein weight-reducing diet, alcohol, liver, and sweetbread) & Chronic lead poisoning

Decreased uric acid levels can be seen in the following:

Drugs such as uricosuric drugs (salicylates, probenecid, allopurinol), estrogen, phenothiazines, indomethacin, corticotrophin ,Syndrome of inappropriate antidiuretic hormone
secretion (SIADH) with hyponatremia,Wilson disease,Fanconi syndrome,Acromegaly,Celiac disease and Xanthinuria

REMARK-Nutritional tips to manage increased Uric acid levels • Drink plenty of fluids • Limit animal proteins • High Fibre foods • Vit C Intake • Antioxidant rich foods

*** End Of Report ***

Page 8 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 09:20PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
LIVER FUNCTION TEST (LFT) - EXTENDED
BILIRUBIN TOTAL,Serum 2.36 mg/dL 0.10 - 1.20
Methodology: Diazonium Ion
DIRECT BILIRUBIN(CONJUGATED), Serum 0.38 mg/dl 0.00-0.20
Methodology: Diazo Method
INDIRECT BILIRUBIN,Serum 1.98 mg/dL 0.80
Methodology: Calculated
SGPT (ALT), SERUM 37.80 U/L 0-35
Methodology: UV without P5P
SGOT (AST) ,SERUM 34.90 U/L 0-40
Methodology: UV without P5P
ALKALINE PHOSPHATASE ,Serum 96.0 U/L 53-128
Methodology: IFCC
GAMMA GLUTAMYL TRANSFERASE (GGT),Serum 18.00 U/L 12.0-58.0
Methodology: IFCC
TOTAL PROTEIN , Serum 8.36 g/dL 6.00-8.30
Methodology: Biuret
Albumin,Serum 4.41 g/dL 3.2-5.20
Methodology: BCG
GLOBULIN,SERUM 3.95 g/dL 2.30-4.50
Methodology: Calculated
A/G Ratio ,Serum 1.12 1.0 - 2.3
Methodology: Calculated
SGOT/SGPT RATIO 0.92
COMMENT
These are group of tests that can be used to detect the presence of liver disease, distinguish among different types of liver disorders, gauge the extent of known liver
damage, and monitor the response to treatment. Most liver diseases cause only mild symptoms initially, but these diseases must be detected early. Some tests are
associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase
and alkaline phosphatase). Conditions with elevated levels of ALT and AST include hepatitis A,B ,C ,paracetamol toxicity etc.Several biochemical tests are useful in the
evaluation and management of patients with hepatic dysfunction. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on
those individuals taking certain medications, such as anticonvulsants, to ensure that the medications are not adversely impacting the person's liver.

Reference ranges are from Teitz fundamental of clinical chemistry 8th ed (2018)

*** End Of Report ***

Page 9 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 08:51PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
KIDNEY FUNCTION TEST (KFT)-BASIC
UREA - SERUM 20.3 mg/dL 19.0 - 44.0
Methodology: Urease UV
CREATININE-SERUM 0.63 mg/dL 0.60-1.30
Methodology: Jaffe Kinetic
URIC ACID - SERUM 3.60 mg/dL 3.50 - 7.20
Methodology: URICASE-POD
SODIUM (SERUM) 140.7 mmol/L 135 - 150
Methodology: ISE
POTASSIUM-SERUM 4.58 mmol/L 3.5 - 5.5
Methodology: ISE
CHLORIDE ,Serum 104.00 mmol/L 94 - 110
Methodology: ISE
BLOOD UREA NITROGEN (BUN) 9.49 mg/dL 8.00-23.0
Methodology: Calculated
BUN/CREATININE RATIO 15.06 Ratio 10-20:1 Normal
Methodology: Calculated
UREA / CREATININE RATIO 32.22 Ratio 40-100:1 Normal
Methodology: Calculated

INTERPRETATION
Kidney function tests are group of tests that can be used to evaluate how well the kidneys are functioning.Creatinine is a waste product produced by muscles from the breakdown
of a compound called creatine. In blood, it is a marker of GFR ,in urine, it can remove the need for 24-hour collections for many analytes or be used as a quality assurance tool
to assess the accuracy of a 24-hour collection . It is removed from the body by the kidneys, which filter almost all of it from the blood and release it into the urine. This test
measures the amount of creatinine in the blood and/or urine.Creatine is part of the cycle that produces energy needed to contract muscles. Both creatine and creatinine are
produced by the body at a relatively constant rate. Since almost all creatinine is filtered from the blood by the kidneys and released into the urine, blood levels are usually a
good indicator of how well the kidneys are working.
REMARK-The amount of creatinine you produce depends on your body size and your muscle mass. For this reason, creatinine levels are usually slightly higher in men than in
women and children.Certain drugs are nephrotoxic hence KFT is done before and after initiation of treatment with these drugs.

Higher creatinine than normal level may be due to: • Blockage in the urinary tract • Kidney problems, such as kidney damage or failure, infection, or reduced blood flow • Loss of
body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure caused by
pregnancy (preeclampsia)
Lower than normal creatinine level may be due to: • Myasthenia Gravis • Muscular dystrophy.Low serum creatinine values are rare; they almost always reflect low muscle mass.

*** End Of Report ***

Page 10 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 08:51PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
LIPID PROFILE BASIC
CHOLESTEROL TOTAL - Serum 155.00 mg/dL <200 Desirable
Methodology: Cholesterol Oxidase,Esterase,Peroxidase 200-239 Borderline high risk
>240 High risk
TRIGLYCERIDES - SERUM 80.00 mg/dL <150
Methodology: Enzymatic, end Point
CHOLESTEROL - HDL (DIRECT) 55.00 mg/dL >40 Recommended Range
Methodology: Direct measure ,polymer-polyanion
NON-HDL CHOLESTEROL 100.00 mg/dL <130
CHOLESTEROL-LDL (DIRECT) 84.00 mg/dL <130 Recommended Range
Methodology: Calculated
VLDL ,SERUM 16.00 mg/dL 0.00 - 45.0
Methodology: Calculated
CHOL/HDL Ratio 2.82 Ratio 3.40-4.40
Methodology: Calculated
LDL/HDL Ratio 1.53 Ratio 1.0-3.5
Methodology: Calculated
HDL/LDL CHOLESTEROL RATIO 0.65 Ratio <3.50
Methodology: Calculated
REFERENCE RANGES AS PER NCEP ATP III GUIDLINES

TOTAL CHOLESTEROL mg/dl HDL mg/dl LDL mg/dl TRIGLYCERIDES mg/dl

Desirable <200 Low <40 Optimal <100 Normal <150
Near Optimal 100-129
Borderline High 200-239 High >60 Borderline High 150-199
Borderline High 130-159
High 160-189 High 200-499
High >240 - -
Very High >190 Very High >500

ALERT!!! 10-12 hours fasting is mandatory for lipid parameters.If not,values might fluctuate.
CLINICAL NOTES-Lipid profile is initial screening tool for abnormalities in lipids. The results of this test can identify certain genetic diseases & can determine approximate risks
for cardiovascular disease, certain forms of pancreatitis. Hypertriglyceridemia is indicative of insulin resistance when present with low HDL & elevated LDL, while elevated TG is
risk factor for coronary artery disease,especially when low HDL is present.TG of 500mg/dL or more can be concerning for development of pancreatitis.*The calculated value for
LDL-C is typically reported as part of the lipid profile as per friedewald equation. When triglycerides are high(>350mg/dl), the equation is no longer valid. In this situation,
the only way to accurately determine LDL-C is to measure it directly.

Remark-Measurements in the same patient can show physiological & analytical variations. 3 serial samples 1 week apart are recomended for Total Cholesterol, TG, HDL & LDL
Cholesterol.As per NCEP guidelines, all adults above the age of 20 years should be screened for lipid status.Selective screening of children above the age of 2 years with a
family history of premature cardiovascular disease or those with at least one parent with high total cholesterol is recommended.NCEP Identifies elevated Triglycerides as an
independent risk factor for Coronary Heart Disease (CHD) .RefFriedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in
plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18;499-502. PubMed ID: 4337382)

*** End Of Report ***

Page 11 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:43PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

IMMUNOLOGY
Test Name Results Unit Bio. Ref. Interval
PSA (PROSTATE SPECIFIC ANTIGEN) -TOTAL
PSA TOTAL ,SERUM 0.273 ng/mL 0.00-4.00
Methodology: CLIA
CLINICAL NOTES:-Prostate-specific antigen (PSA)is a 34-kD glycoprotein produced almost exclusively by the prostate gland.PSA is normally present in the blood at very
low levels. Increased levels of PSA may suggest the presence of prostate cancer.

1.Immediate PSA testing following digital rectal examination, ejaculation, prostatic massage, indwelling catheterization, ultrasonography and needle biopsy of prostate is not
recommended as they falsely elevate levels
2. PSA values regardless of levels should not be interpreted as absolute evidence of the presence or absence of disease. All values should be correlated with clinical
findings and other investigations
3. Physiological decrease in PSA level by 18% has been observed in sedentary patients either due to supine position or suspended sexual activity

Clinical Use
• An aid in the early detection of Prostate cancer when used in conjunction with Digital rectal examination in males more than 50 years of age and in those with two or more
affected first degree relatives.
• Follow up and management of Prostate cancer patients
• Detect metastatic or persistent disease in patients following surgical or medical treatment of Prostate cancer

NOTE
PSA levels can be also increased by prostatitis, irritation, benign prostatic hyperplasia (BPH), and recent ejaculation, producing a false positive result. Digital rectal
examination (DRE) has been shown in several studies to produce an increase in PSA. However, the effect is clinically insignificant, since DRE causes the most substantial
increases in patients with PSA levels already elevated over 4.0 ng/mL.

Obesity has been reported to reduce serum PSA levels. Delayed early detection may partially explain worse outcomes in obese men with early prostate cancer. After
treatment, higher BMI also correlates to higher risk of recurrence.specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J
Urol. 1995 Sep;154(3):1090-1095. doi:10.1016/s0022-5347(01)66984-2

REFRENCE
1. Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020 Feb 25;58(3):326-339. doi: 10.1515/cclm-2019-0693
2. Catalona WJ: Prostate cancer screening. Med Clin North Am. 2018 Mar;102(2):199-214. doi:10.1016/j.mcna.2017.11.001
3. Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA.
1995:274(15);214-1220
4. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;362:k3519.
doi:10.1136/bmj.k3519

*** End Of Report ***

Page 12 of 13
 Name : Mr. MOKTAR KHAN Patient UID. : 6312097
Age/Gender : 21 Yrs/Male Visit No. : 45332411010002
Referred Client : LDPLW3355-B K T Collected on : 01-Nov-2024 03:37PM
Referred By : NA Received on : 01-Nov-2024 05:10PM
Doctor Name : Dr. K MAL Reported on : 01-Nov-2024 06:45PM
Sample Type : Serum - W2567904,Whole Blood EDTA - W2567903,Sod.Fluoride - R - W2567902

IMMUNOLOGY
Test Name Results Unit Bio. Ref. Interval
THYROID PROFILE : T3, T4 & TSH(TFT)
TRIODOTHYRONINE TOTAL (T3),Serum 1.20 ng/mL 0.70-2.04
Methodology: ECLIA
THYROXINE TOTAL (T4),Serum 6.85 ug/dl 4.6-10.5
Methodology: ECLIA
THYROID STIMULATING HORMONE (TSH),Serum 1.43 µIU/ml 0.35-4.94
Methodology: CMIA
NOTE-TSH levels are subject to circardian variation,reaching peak levels between 2-4 AM and min between 6-10 PM. The variation is the order of 50% hence time of the day has influence on the
measures serum TSH concentration.Dose and time of drug intake also influence the test result.
Transient increase in TSH levels or abnormal TSH levels can be seen in some non thyroidal conditions,simoultaneous measurement of TSH with free T4 is useful in evaluating differantial diagnosis.

INTERPRETATION-Ultra Sensitive 4th generation assay

1.Primary hyperthyroidism is accompanied by ↑serum T3 & T4 values along with ↓ TSH level.
2.Low TSH,high FT4 and TSH receptor antibody(TRAb) +ve seen in patients with Graves disease
3.Low TSH,high FT4 and TSH receptor antibody(TRAb) -ve seen in patients with Toxic adenoma/Toxic Multinodular goiter
4.HighTSH,Low FT4 and Thyroid microsomal antibody increased seen in patients with Hashimotos thyroiditis
5.HighTSH,Low FT4 and Thyroid microsomal antibody normal seen in patients with Iodine deficiency/Congenital T4 synthesis deficiency
6.Low TSH,Low FT4 and TRH stimulation test -Delayed response seen in patients with Tertiary hypothyroidism
7.Primary hypothyroidism is accompanied by ↓ serum T3 and T4 values & ↑serum TSH levels
8.Normal T4 levels accompanied by ↑ T3 levels and low TSH are seen in patients with T3 Thyrotoxicosis
9.Normal or↓ T3 & ↑T4 levels indicate T4 Thyrotoxicosis ( problem is conversion of T4 to T3)
10.Normal T3 & T4 along with ↓ TSH indicate mild / Subclinical Hyperthyroidism .
11.Normal T3 & ↓ T4 along with ↑ TSH is seen in Hypothyroidism .
12.Normal T3 & T4 levels with ↑ TSH indicate Mild / Subclinical Hypothyroidism .
13.Slightly ↑ T3 levels may be found in pregnancy and in estrogen therapy while ↓ levels may be encountered in severe illness , malnutrition , renal failure and during therapy with drugs like
propanolol.
14.Although ↑ TSH levels are nearly always indicative of Primary Hypothroidism ,rarely they can result from TSH secreting pituitary tumours.

DURING PREGNANCY - REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association)
1st Trimester : 0.10-2.50 uIU/mL
2nd Trimester : 0.20-3.00 uIU/mL
3rd Trimester : 0.30-3.00 uIU/mL
The production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.

REMARK-Assay results should be interpreted in context to the clinical condition and associated results of other investigations. Previous treatment with corticosteroid therapy may result in lower TSH
levels while thyroid hormone levels are normal. Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. Abnormal thyroid test findings often found in
critically ill patients should be repeated after the critical nature of the condition is resolved.TSH is an important marker for the diagnosis of thyroid dysfunction.Recent studies have shown that the
TSH distribution progressively shifts to a higher concentration with age ,and it is debatable whether this is due to a real change with age or an increasing proportion of unrecognized thyroid disease in
the elderly.

*** End Of Report ***

Page 13 of 13
 Name : Mr. MUKTHAR KHAN Patient UID. : 6308780
Age/Gender : 21 Yrs/Male Visit No. : 45332410310003
Referred Client : LDPLW3355-B K T Collected on : 31-Oct-2024 04:15PM
Referred By : NA Received on : 31-Oct-2024 05:31PM
Doctor Name : Dr. K MAL Reported on : 31-Oct-2024 07:42PM
Sample Type : Urine - W2567192,Urine - W2567190

CLINICAL PATHOLOGY
Test Name Results Unit Bio. Ref. Interval
URINE EXAMINATION ROUTINE (CUE)
PHYSICAL EXAMINATION
VOLUME 25.00 mL
COLOUR PALE YELLOW PALE YELLOW
APPEARANCE CLEAR CLEAR
pH 6.00 6.0-7.5
Methodology: Double Indicator
SPECIFIC GRAVITY 1.025 1.003-1.035
Methodology: Refractometric
CHEMICAL EXAMINATION
ALBUMIN/PROTEIN NEGATIVE NEGATIVE
Methodology: Protein error of indicator
GLUCOSE-URINE NEGATIVE NEGATIVE
Methodology: Oxidase Peroxidase Reaction
KETONES NEGATIVE NEGATIVE
Methodology: Rotheras Method
UROBILINOGEN NOT INCREASED NOT INCREASED
Methodology: Modified Ehrlich Reaction
BILIRUBIN NEGATIVE NEGATIVE
Methodology: DIAZOTIZATION
BLOOD NEGATIVE NEGATIVE
Methodology: Peroxidase Reaction
NITRITE NEGATIVE NEGATIVE
Methodology: Diazo Method
LEUCOCYTES NEGATIVE NEGATIVE
Methodology: Diazo Method
MICROSCOPIC EXAMINATION (/HPF)
PUS CELLS 1-2 /hpf 0-1/hpf
EPITHELIAL CELLS 1-2 /hpf NIL
RBC NIL
BACTERIA ABSENT ABSENT
CASTS ABSENT ABSENT
CRYSTALS ABSENT ABSENT
OTHERS NIL

*** End Of Report ***

Page 1 of 2
Page 2 of 2
 Name : Mr. MUKTHAR KHAN Patient UID. : 6308780
Age/Gender : 21 Yrs/Male Visit No. : 45332410310003
Referred Client : LDPLW3355-B K T Collected on : 31-Oct-2024 04:15PM
Referred By : NA Received on : 31-Oct-2024 05:31PM
Doctor Name : Dr. K MAL Reported on : 31-Oct-2024 07:42PM
Sample Type : Urine - W2567192,Urine - W2567190

CLINICAL PATHOLOGY
Test Name Results Unit Bio. Ref. Interval
URINE EXAMINATION ROUTINE (CUE)
PHYSICAL EXAMINATION
VOLUME 25.00 mL
COLOUR PALE YELLOW PALE YELLOW
APPEARANCE CLEAR CLEAR
pH 6.00 6.0-7.5
Methodology: Double Indicator
SPECIFIC GRAVITY 1.025 1.003-1.035
Methodology: Refractometric
CHEMICAL EXAMINATION
ALBUMIN/PROTEIN NEGATIVE NEGATIVE
Methodology: Protein error of indicator
GLUCOSE-URINE NEGATIVE NEGATIVE
Methodology: Oxidase Peroxidase Reaction
KETONES NEGATIVE NEGATIVE
Methodology: Rotheras Method
UROBILINOGEN NOT INCREASED NOT INCREASED
Methodology: Modified Ehrlich Reaction
BILIRUBIN NEGATIVE NEGATIVE
Methodology: DIAZOTIZATION
BLOOD NEGATIVE NEGATIVE
Methodology: Peroxidase Reaction
NITRITE NEGATIVE NEGATIVE
Methodology: Diazo Method
LEUCOCYTES NEGATIVE NEGATIVE
Methodology: Diazo Method
MICROSCOPIC EXAMINATION (/HPF)
PUS CELLS 1-2 /hpf 0-1/hpf
EPITHELIAL CELLS 1-2 /hpf NIL
RBC NIL
BACTERIA ABSENT ABSENT
CASTS ABSENT ABSENT
CRYSTALS ABSENT ABSENT
OTHERS NIL

*** End Of Report ***

Page 1 of 2
 Name : Mr. MUKTHAR KHAN Patient UID. : 6308780
Age/Gender : 21 Yrs/Male Visit No. : 45332410310003
Referred Client : LDPLW3355-B K T Collected on : 31-Oct-2024 04:15PM
Referred By : NA Received on : 31-Oct-2024 05:31PM
Doctor Name : Dr. K MAL Reported on : 02-Nov-2024 05:57PM
Sample Type : Urine - W2567192,Urine - W2567190

MICROBIOLOGY
Test Name Results Unit Bio. Ref. Interval
CULTURE -URINE (AEROBIC )-12 DRUGS
Organism NO AEROBIC PATHOGEN GROWN AFTER 48 HOURS OF
INCUBATION AT 37 °C.
COMMENTS:The urinary bladder and urinary tract are normally sterile. The urethra however may contain a few commensals and also the perineum (wide variety of Gram
positive and Gram negative organisms) which can contaminate urine when it is being collected. A bacterial count of 10^5 organisms/ml or more from a fresh clean – catch
urine specimen, indicates a urinary infection. After count of 10^4 10^5 / ml, could mean infection or contamination. A repeat specimen is indicated. A count of less than 10^4
/ ml is nearly always due to contamination unless the urine was cultured antimicrobial treatment had been started. It is important to interpret culture counts in relation to the
patients clinical condition.

CAUSES OF STERILE PYURIA:Patient on antibiotics,Contamination of the sample with vaginal leukocytes in female patients,Urinary tract stones, Renal papillary
necrosis,Polycystic kidneys,Interstitial cystitis,Prostatitis,Infection may be due to fastidious org.requiring special culture. Fewer than 100,000 colony-forming units (cfu) per
mL reported - eg it may be that urine was diluted by high fluid intake or an organism may be slow-growing.

*** End Of Report ***

Page 2 of 2